Meet the Speakers

  • Monet Goode

    FOUNDER

  • Emmett Marsh

    DESIGN DIRECTOR

  • Eleanor Parks

    SUSTAINABILITY DIRECTOR

  • Karl Holland

    SALES MANAGER

  • Jaya Dixon

    MARKETING DIRECTOR

Agenda

  • Speakers:

    • Name, Title, Company

    • Name, Title, Company

    Description:

    • This session aligns senior leaders around the realities shaping medication access today, moving beyond assumptions and high-level narratives to focus on what is actually happening across the system. The discussion is designed to establish a shared understanding of the operational, financial, and structural challenges impacting patient access today. By bringing forward real-world perspectives and aligning on where the system is working and where it is not, this opening ensures every conversation that follows is rooted in relevance, urgency, and execution.

  • Speakers:

    • Name, Title, Company

    • Name, Title, Company

    Description:

    • Access continues to evolve under increasing pressure from policy changes, rising costs, and growing system complexity. This keynote delivers a comprehensive, executive-level perspective on the current and future state of access. The focus is on connecting macro-level trends to real-world implications, highlighting where organizations must adapt and where new strategies are required. Attendees will walk away with a clear understanding of how these forces are shaping the patient journey and what it will take to ensure patients can move from prescription to therapy start in a more predictable and efficient way.

  • Speakers:

    • Name, Title, Company

    • Name, Title, Company

    Description:

    • Coverage is often viewed as the endpoint, but in reality it is only the beginning. This session takes a critical look at how coverage policies perform once they are put into practice. The discussion focuses on where breakdowns occur between policy design and real-world execution, how those gaps create delays and barriers, and what must be addressed to improve time to therapy. This is a candid evaluation of performance, with a focus on identifying practical opportunities for improvement across the system.

  • Speakers:

    • Name, Title, Company

    • Name, Title, Company

    Description:

    • This session will feature perspectives on utilization management and how policies are designed to support clinically appropriate care within the healthcare system. Panelists will discuss considerations that inform policy development and share perspectives on opportunities to enhance clarity, consistency, and collaboration across stakeholders involved in patient access processes.

  • Speakers:

    • Name, Title, Company

    • Name, Title, Company

    Description:

    • Even when coverage is secured, financial barriers continue to prevent patients from starting or staying on therapy. This session focuses on the growing affordability gap and the complexities surrounding co-pay support, foundation funding, and patient assistance programs. The discussion will explore how fragmentation across programs, processes, and funding sources contributes to delays and how stronger coordination and strategy can help close the gap.

      At the same time, not all patients are able to access therapy through traditional coverage pathways. As these pathways become more constrained, organizations are exploring alternative approaches to support patient access, including the use of alternative funding pathways. This conversation brings forward how these strategies are being evaluated and implemented in practice, alongside the role of foundations and other support mechanisms, and the broader implications across the access ecosystem.

      The emphasis is on ensuring that access strategies are designed to move patients forward, whether through traditional coverage models or emerging pathways, and that patients are able to initiate and stay on therapy without unnecessary delay.

  • Speakers:

    • Name, Title, Company

    • Name, Title, Company

    Description:

    • Distribution strategy has a direct and measurable impact on how quickly and effectively patients can access therapy. This session examines how strategic decisions related to distribution influence provider workflows, pharmacy operations, and patient experience. The conversation focuses on identifying areas of misalignment, understanding system-wide implications, and exploring approaches that better support coordinated, efficient access.

  • Speakers:

    • Name, Title, Company

    • Name, Title, Company

    Description:

    • HUB models are expected to deliver more value than ever before, yet performance and alignment remain inconsistent across the landscape. This session takes a critical look at how HUB programs are operating today, where expectations are being met, and where they are falling short. The discussion focuses on what needs to evolve to better support patients, providers, and broader access strategies, with an emphasis on accountability, efficiency, and measurable outcomes.

  • Speakers:

    • Name, Title, Company

    • Name, Title, Company

    Description:

    • Even when coverage is secured, financial barriers continue to prevent patients from starting or staying on therapy. This session focuses on the growing affordability gap and the complexities surrounding co-pay support, foundation funding, and patient assistance programs. The discussion will explore how fragmentation across programs, processes, and funding sources contributes to delays and how stronger coordination and strategy can help close the gap.

      At the same time, not all patients are able to access therapy through traditional coverage pathways. As these pathways become more constrained, organizations are exploring alternative approaches to support patient access, including the use of alternative funding pathways. This conversation brings forward how these strategies are being evaluated and implemented in practice, alongside the role of foundations and other support mechanisms, and the broader implications across the access ecosystem.

      The emphasis is on ensuring that access strategies are designed to move patients forward, whether through traditional coverage models or emerging pathways, and that patients are able to initiate and stay on therapy without unnecessary delay.

  • Speakers:

    • Name, Title, Company

    • Name, Title, Company

    Description:

    • Strategic decisions around access ultimately show up in the day-to-day experience of patients and care teams. This session brings forward those real-world impacts, highlighting how policies, processes, and system design influence workflows, patient progression, and overall outcomes. The focus is on ensuring that future strategies are informed by the realities of execution and grounded in what is required to support patients effectively.

  • Speakers:

    • Name, Title, Company

    • Name, Title, Company

    Description:

    • We close with a forward-looking discussion focused on what it will take to move the system forward. This panel brings together experienced leaders to align on priorities, identify actionable strategies, and define the path ahead. The conversation is centered on reducing friction, improving coordination, and ensuring that efforts across the ecosystem translate into meaningful progress for patients. The goal is to leave with clarity, alignment, and a shared commitment to driving change.